GLUE

Monte Rosa Therapeutics, Inc.

Health Care

$15.84 0.11 (0.69%) Thu End-of-day close · Aug 13, 2026

4/10of the Ten Checks passingunchanged since Wednesday’s closeSame Ten Checks for every stock — a measurement, not a ranking or a call to act. How the Ten Checks work →

New to the Ten Checks? Learn to read them

Can you read a chart the way the Ten Checks do? Try today’s Daily Read

Has GLUE ever passed all Ten Checks?Monte Rosa Therapeutics, Inc.

history · not a forecast

GLUE has never passed all Ten Checks on the same day since it listed in 2021 — a clean sweep is rare by design. Its closest read so far: 9/10, most recently Jul 2026.

6-month history — checks vs. price

Price on the left axis; checks passing (0–10) on the right.

Close ($)Checks (0–10)

Aug 13, 20264/10 checks$15.84closelatest · hover the chart to scan

Checks passing over the last 126 sessions count only · not price

Common questions about GLUE’s checks

How many technical checks does GLUE pass right now?

As of the Aug 13, 2026 close, GLUE passes 4 of 10 fixed technical checks — the checks not passing: long-term trend rising, holding above short-term average, not overextended, no recent earnings miss, outperforming the market, adequate stop room.

Why does GLUE fail the "holding above short-term average" check?

GLUE closed at $15.84, 5.5% below its 9-day average ($16.77), so this momentum check fails. It passes again on a close above $16.77.

What price would change GLUE's check count?

The nearest flip level is "stop distance within range" fails on a close outside $15.83 – $16.86. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.

Factual measurements from the latest scan — not investment advice.

Explore more See all stocks passing 9+ checks → Browse the full S&P 500 →